GLP-1 implant from Vivani Medical aims to help patients stay on treatment
Michael Siluk | UCG | Universal Images Group | Getty Images Losing weight with GLP-1 drugs is only…
AstraZeneca stock dives 9% after heart drug trial misses target
Shares of AstraZeneca fell as much as 9% after a late-stage clinical trial for a heart disease failed…
Employers aren’t expanding coverage of GLP-1 obesity drugs: survey
A version of this article first appeared in CNBC’s Healthy Returns newsletter, which brings the latest health-care news…
Planned Parenthood can bill Medicaid again
Planned Parenthood and two smaller regional abortion providers are resuming billing Medicaid for services other than abortion after…
Utah now lets AI refill prescriptions but doctors are wary
WASHINGTON (AP) — A prescription refill program that quietly launched in Utah earlier this year has kicked off…
Medicare obesity drug GLP-1 coverage starting July 1
Millions of older Americans in Medicare are about to receive a benefit that has never existed before: coverage…
Ebola outbreak: Experts say USAID closure made virus harder to contain
Doctors Without Borders health workers wearing personal protective equipment move through the isolated red zone to monitor patients,…
Cuba’s healthcare system, once a source of national pride, is in decline
BATABANO, Cuba (AP) — After two surgeries and several rounds of radiation therapy over the past four years…
Medicare obesity drugs: Walmart, CVS step in to help seniors
A version of this article first appeared in CNBC’s Healthy Returns newsletter, which brings the latest health-care news…
Eli Lilly, Regeneron in FDA PreCheck manufacturing program
Eli Lilly and Regeneron are among the first seven companies the U.S. Food and Drug Administration selected for…
Barbers bring personal grooming therapy to Kenya’s mental health hospital
NAIROBI, Kenya (AP) — At Kenya ’s largest mental health referral hospital, male patients encounter a different kind…
Abivax stock soars after new data on bowel disease medicine
Shares of French biotech company Abivax soared Tuesday after it released fresh data on its lead drug for…